Drug Discovery and Development
CARBOGEN AMCIS Shanghai site achieves successful outcome in unannounced NMPA GMP inspection
CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and active pharmaceutical ingredient (API) manufacturing company, today announces its Shanghai facility has successfully completed an unannounced...
BioLife Solutions wins Interphex 2026 biotech innovation award for CellSeal CryoCase
BioLife Solutions, a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) market, has received the Interphex...
US$ 8.5 million investment in malaria and other R&D projects planned among pharma giants
The global health innovative technology (GHIT) fund has announced a total investment of approximately JPY 1.37 billion (US$ 8.5 million) in five R&D projects...
New non-compromise early-phase progression accelerator launched
CARBOGEN AMCIS introduces Sprint for early-phase development, a new, phase-appropriate approach designed to accelerate early-phase progression while maintaining scientific rigour.
Sprint has been designed to...
Dayspring Pharma announces phase 2 trial of CG2001 foam met primary endpoint in Chinese adult men with androgenetic alopecia
Dayspring Pharma has announced top-line data from its phase 2 clinical trial of CG2001 foam in male patients with androgenetic alopecia (AGA). The trial met...
ImmunoForge to accelerate central nervous system drug development with innovative blood-brain barrier shuttle platform
ImmunoForge, a clinical-stage biopharmaceutical company specializing in treatments for rare and muscular diseases, is poised to redefine central nervous system (CNS) drug delivery with...
Expanded antibody portfolio enhances detection of biologics and therapeutics for bioanalytical applications
Bio-Rad Laboratories, a global leader in life science research and clinical diagnostics products, has extended its range of recombinant monoclonal anti-idiotypic antibodies, with the introduction...
MHRA approves new high dose regimen of Spinraza (nusinersen) for spinal muscular atrophy
Biogen announces that the high dose regimen of Spinraza® (nusinersen), has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) for the treatment...
Clinical Trials Insight
Calla Lily doses first patients in clinical trial for intravaginal drug delivery platform for threatened miscarriage
Calla Lily Clinical Care, a women’s health-focused medical technology company, has announced dosing of the first patients in the ‘freedom’ clinical trial.
The study, funded...
Inhibrx provides clinical update on ozekibart in late line colorectal cancer
Inhibrx Biosciences, a clinical-stage biopharmaceutical company focused on developing novel biologic therapeutic candidates, has released updated interim data from its phase 1/2 study evaluating...
Positive phase 1 data for RAG-17 in amyotrophic lateral sclerosis patients with mutations in the superoxide dismutase 1 gene
Ractigen Therapeutics, a clinical-stage biopharmaceutical company focused on developing next-generation RNA-based medicines, has announced positive preliminary data from the single ascending dose (SAD) phase...
Dayspring Pharma announces phase 2 trial of CG2001 foam met primary endpoint in Chinese adult men with androgenetic alopecia
Dayspring Pharma has announced top-line data from its phase 2 clinical trial of CG2001 foam in male patients with androgenetic alopecia (AGA). The trial met...
Novo Nordisk to seek oral sickle cell therapy approval after phase 3 success
A phase 3 trial of Novo Nordisk’s once-daily tablet has met both co-primary endpoints, reducing vaso-occlusive crises (VOC) and increasing haemoglobin (Hb) response in...
VIDEOS
Pharma in Healthcare
Marty Makary resigns as chief of the Food and Drug Administration
Marty Makary, US Food and Drug Administration (FDA) commissioner, is leaving his post, US president Donald Trump said yesterday Tuesday 12 May 2026.
Mr Trump...
Global nasal sprays market to reach US$ 29.7 billion by 2036, driven by rising allergy cases and non-oral drug demand
According to the latest market analysis by Future Market Insights, the global nasal sprays market is poised for consistent expansion, supported by rising incidence of allergic rhinitis,...
US$ 8.5 million investment in malaria and other R&D projects planned among pharma giants
The global health innovative technology (GHIT) fund has announced a total investment of approximately JPY 1.37 billion (US$ 8.5 million) in five R&D projects...
MHRA approves new high dose regimen of Spinraza (nusinersen) for spinal muscular atrophy
Biogen announces that the high dose regimen of Spinraza® (nusinersen), has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) for the treatment...
Cell line development market to reach $8.95 billion by 2031 with Gene & Cell Therapy manufacturing growing at 10.88%
According to Mordor Intelligence, the global cell line development market is projected to grow from USD 4.97 billion in 2025 to USD 5.48 billion in 2026, and is expected to...
Technology and Automation
Bio-Rad launches PTC Harmony 96 and PTC Harmony Deepwell thermal cyclers
Bio-Rad Laboratories has launched the PTC Harmony Thermal Cycler line, designed to offer broader access to optimised workflows for PCR applications such as sequencing,...
PCI Pharma Services announces US$1 billion expansion of US sterile fill-finish and drug-device delivery combination capabilities
PCI Pharma Services, a world-leading integrated global contract development and manufacturing organisation (CDMO) focused on innovative biologic and small molecule therapies, has announced a...
Ledger Run first to bring AI-powered automation to clinical trial payments
Ledger Run, a leader in clinical trial financial management solutions, has announced significant upgrades to its ClinRun platform, including intelligent automation and expanded flexibility to accelerate...
Trelleborg strengthens quality compliance with ISO certification in Costa Rica
Trelleborg Medical Solutions’ manufacturing site in Costa Rica has earned ISO 13485:2016 certification, helping ensure product consistency and compliance.
ISO 13485:2016 is a process-focused quality framework...
Liebherr expands UK lab portfolio
Commercial refrigeration specialist Liebherr has introduced seven high performance countertop and fully integrated under bench models in their UK lab and healthcare range.
These include...
Pharma packaging and logistics
Alcami to acquire contract packaging organisation Tjoapack
Alcami Corporation, a leading US-based contract development and manufacturing organisation (CDMO), has entered into a definitive agreement to acquire Tjoapack, a leading global contract...
PCI Pharma Services announces US$1 billion expansion of US sterile fill-finish and drug-device delivery combination capabilities
PCI Pharma Services, a world-leading integrated global contract development and manufacturing organisation (CDMO) focused on innovative biologic and small molecule therapies, has announced a...
4basebio announces major expansion to support the growing demand of RUO and HQ synthetic DNA with lease of an innovation hub and manufacturing facility...
4basebio PLC, a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, has announced a significant expansion into a new innovation hub...
Delivery routes expanded and order cut-off times for midwest and west coast customers extended
Smith Drug Company, the industry's largest wholesaler dedicated exclusively to independent retail and long-term care pharmacies, has announced a series of operational enhancements designed...
Atelerix enters agreement with Cherry Biotech to integrate non-cryogenic transport solutions with advanced organoid models
Atelerix, a biotech company revolutionising cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it has entered a partnership with...
Events and conferences
Interphex Week Tokyo 2026 organises show floor around manufacturing, packaging, inspection and digital production technologies
Interphex Week Tokyo 2026 will take place from 20-22 May at Makuhari Messe, bringing together six specialised exhibitions and a concurrent regenerative medicine expo...
AI Drug Discovery & Development Summit (AIDDD)
27-29 October 2026
Boston Marriott Copley Place, Boston, USA
The AI Drug Discovery & Development Summit (AIDDD) is the meeting place for the innovators redefining how...
Global Drug Delivery and Formulation (DDF) Summit
18-20 May Berlin, Germany
The Global Drug Delivery and Formulation (DDF) Summit is Europe’s premier gathering for professionals at the forefront of pharmaceutical development and drug delivery...
Chemspec Europe reveals new details about 2026 conference programme
6–7 May 2026 Koln, Germany
Chemspec Europe has unveiled further details of its highly anticipated conference programme, offering attendees fresh insight into the key...
Inaugural International Brain Health Conference 2026 to focus on early intervention before dementia
International Brain Health Conference 2026 18–19 May 2026 Sheraton Grand Hotel, Edinburgh, UK
An international conference bringing together global leaders in neuroscience, clinical research, public health, and...
Funding and Finance
Evotec SE successfully places €116.1 million convertible bonds
Evotec SE has placed senior unsecured convertible bonds due 2033, convertible into new and/or existing no-par value ordinary bearer shares of the company, in...
US$ 8.5 million investment in malaria and other R&D projects planned among pharma giants
The global health innovative technology (GHIT) fund has announced a total investment of approximately JPY 1.37 billion (US$ 8.5 million) in five R&D projects...
Evotec announces chief financial officer transition
Evotec SE has announced that chief financial officer (CFO) Paul Hitchin will step down on 30 April 2026 for personal reasons unrelated to the...
PlaqueTec closes $5 million financing
PlaqueTec, a medtech company pioneering intracoronary liquid biopsy to identify inflammatory drivers of cardiovascular disease (CVD), has raised $5 million. The oversubscribed financing round was...
Ledger Run first to bring AI-powered automation to clinical trial payments
Ledger Run, a leader in clinical trial financial management solutions, has announced significant upgrades to its ClinRun platform, including intelligent automation and expanded flexibility to accelerate...
- Advertisement -
- Advertisement -
- Advertisement -
MOST POPULAR POSTS
© 2026 Pharma Press Publishing.